U.S. Markets open in 7 hrs, 37 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,433.71 | -17.24 | -0.16% |
| NASDAQ | 2,169.18 | -6.83 | -0.31% |
| S&P 500 | 1,105.65 | -0.59 | -0.05% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 0.8701 10:49 AM EST | |
|---|---|---|
| Day High | 0.928 09:44 AM EST |
|
| Range | 0.06 |
| Volume | 174,943 | |
|---|---|---|
| 30-Day Avg Vol | 367,000 |
|
| Difference | -52.33% |
| Market Cap | 36.31 M | |
|---|---|---|
| Mkt Cap Chg | 408,073 |
| Shares Out | 40.80 M | |
|---|---|---|
| % Shrs Traded | 0.43% | |
| 1yr EPS Est | -0.33 |
| 52-Wk Low | 0.21 | |
|---|---|---|
| 52-Wk High | 3.55 |
|
| Range | 3.34 |
| Prev Close | 0.88 11/23/09 | |
|---|---|---|
| Today's Open | 0.88 | |
| Change | 0.00% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 803,238.00 |
| Revenue (LFY) | 2.60 M | |
|---|---|---|
| Earnings (LFY) | -59.22 M | |
| Earnings (MRQ) | -7.01 M | |
| Next Earn Est | -0.175 | |
| Next Earnings | 01/13/2010 |
|
| EPS (TTM) | -0.59 | |
| 1yr EPS Growth | 38.89% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -2.00 | |
| PEG Ratio | — | |
| Return on Equity | -295.23 | |
| Beta | 2.62 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
With its work in the cutting-edge field of RNA interference, MDRNA (formerly Nastech Pharmaceutical) hopes it's getting to the very source of disease. The company, which once focused on developing drugs ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.175 1/13/10 | — — |
—
—
|
| Last Quarter | -0.19 9/30/09 | -0.17 9/30/09 |
0.02
Beat
|
| 2 Quarters Ago | — 6/30/09 | -0.21 6/30/09 |
—
—
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 64,000.00 | 2.61 M |
| Gross Profit | -680,000.00 | -4.41 M |
| Operating Income | -6.73 M | -50.68 M |
| Net Income | -7.01 M | -59.22 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts